Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Days At Home, Treatment Pathways, and Equity in Newly Diagnosed Glioblastoma: A Population-Based Cohort Study in Ontario
EF 2025-26
Résumé
Glioblastoma (GBM) is the most common malignant brain tumour in adults and remains almost uniformly fatal despite standard therapy with surgery, radiotherapy, and temozolomide. Traditional outcomes such as overall or progression-free survival fail to capture what patients and families value most, their ability to live at home and maintain independence. “Days At Home” (DAH), defined as the number of days alive and out of hospitals or institutions, is an emerging, patient-centred measure that reflects both survival and quality of life.
This project will use linked, population-based administrative data from Ontario (ICES) to study adults newly diagnosed with GBM between 2007 and 2023. The objectives are to:
(1) Describe DAH at 90, 180 and 365 days after diagnosis overall and by treatment pathway (biopsy, resection, chemoradiation, palliative radiotherapy).
(2) Validate DAH as a meaningful endpoint by testing its relationship with case-mix, readmissions, and overall survival.
(3) Examine whether socioeconomic deprivation or rural residence are associated with DAH and survival, exploring mediators such as treatment completion, centre volume, and access to home care.
Using quantile and Cox regression, and a LASSO-based prognostic model for DAH-180, this study will generate the first provincial benchmarks for DAH in GBM. Results will identify modifiable inequities and inform provincial cancer-care pathways that promote timely treatment and adequate home-care supports. By shifting focus from survival alone to time spent at home, this research aligns health-system evaluation with outcomes that matter most to patients and families.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572983
Name
Saini Jasleen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Days At Home, Treatment Pathways, and Equity in Newly Diagnosed Glioblastoma: A Population-Based Cohort Study in Ontario
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Administrative Health Data; Days At Home (Dah); Glioblastoma; Health Equity; Neuro-Oncology; Patient-Centred Outcomes; Population-Based Cohort; Prognostic Modelling; Quality Of Life; Socioeconomic Deprivation
Abstract
Glioblastoma (GBM) is the most common malignant brain tumour in adults and remains almost uniformly fatal despite standard therapy with surgery, radiotherapy, and temozolomide. Traditional outcomes such as overall or progression-free survival fail to capture what patients and families value most, their ability to live at home and maintain independence. “Days At Home” (DAH), defined as the number of days alive and out of hospitals or institutions, is an emerging, patient-centred measure that reflects both survival and quality of life.
This project will use linked, population-based administrative data from Ontario (ICES) to study adults newly diagnosed with GBM between 2007 and 2023. The objectives are to:
(1) Describe DAH at 90, 180 and 365 days after diagnosis overall and by treatment pathway (biopsy, resection, chemoradiation, palliative radiotherapy).
(2) Validate DAH as a meaningful endpoint by testing its relationship with case-mix, readmissions, and overall survival.
(3) Examine whether socioeconomic deprivation or rural residence are associated with DAH and survival, exploring mediators such as treatment completion, centre volume, and access to home care.
Using quantile and Cox regression, and a LASSO-based prognostic model for DAH-180, this study will generate the first provincial benchmarks for DAH in GBM. Results will identify modifiable inequities and inform provincial cancer-care pathways that promote timely treatment and adequate home-care supports. By shifting focus from survival alone to time spent at home, this research aligns health-system evaluation with outcomes that matter most to patients and families.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Saini, Jasleen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~